Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Albireo Pharma Inc
(NQ:
ALBO
)
34.86
USD
-0.22 (-0.63%)
Official Closing Price
Updated: 4:24 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Albireo Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Albireo Spotlights Global Patient Communities on Rare Disease Day
Today 8:30 EST
From
GlobeNewswire News Releases
Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
Today 0:31 EST
ALBO earnings call for the period ending December 31, 2020.
Tags
ALBO
Market News
From
Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NVCR
AFIB
CLBS
From
Benzinga
Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
February 25, 2021
From
GlobeNewswire News Releases
Albireo to Participate in Cowen and H.C. Wainwright Global Investor Conferences
February 23, 2021
From
GlobeNewswire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
ZIOP
MYGN
HBIO
From
Benzinga
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
February 18, 2021
Conference call and webcast to be held at 10:00 a.m. ET
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2021
From
GlobeNewswire News Releases
Albireo Presents Odevixibat Commercialization Road to $1 Billion
February 11, 2021
From
GlobeNewswire News Releases
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
January 25, 2021
From
GlobeNewswire News Releases
Albireo Recognizes International Alagille Syndrome Awareness Day 2021
January 22, 2021
Albireo supports the Alagille syndrome community to advocate for more education and new treatment advances for rare cholestatic liver diseases
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 14, 2021
From
GlobeNewswire News Releases
Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 06, 2021
From
GlobeNewswire News Releases
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
January 05, 2021
From
GlobeNewswire News Releases
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
December 17, 2020
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2020
From
GlobeNewswire News Releases
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
December 08, 2020
From
GlobeNewswire News Releases
How The Parts Add Up: DWAS Headed For $77
November 18, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ...
Tags
TRIB
News
Benzinga
From
Benzinga
New Phase 3 Data at AASLD Show Durable Response to Odevixibat in a Rare Pediatric Liver Disease
November 13, 2020
From
GlobeNewswire News Releases
Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences
November 12, 2020
From
GlobeNewswire News Releases
Albireo Reports Q3 2020 Financial Results and Provides Business Update
November 05, 2020
From
GlobeNewswire News Releases
Albireo’s Odevixibat PFIC Phase 3 Results Accepted for AASLD Late-Breakers
November 02, 2020
From
GlobeNewswire News Releases
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
October 23, 2020
From
GlobeNewswire News Releases
Cramer Gives His Opinion On Cloudera, Barrick Gold And More
October 20, 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is struggling because it has real ...
Tags
TMO
Market News
BRKR
From
Benzinga
IEIH's Holdings Imply 17% Gain Potential
October 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Albireo Recognizes PFIC Awareness Day 2020
October 05, 2020
Albireo stands together with the PFIC community to highlight critical need for education and advances in research for rare cholestatic liver diseases
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2020
From
GlobeNewswire News Releases
First Week of November 20th Options Trading For Albireo Pharma
September 24, 2020
Investors in Albireo Pharma Inc (ALBO) saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALBO...
Tags
Stocks
From
Market News Video
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.